WHO ICTRP trial
A phase I/II post-cord blood HCT dendritic cell vaccination trial directed…
NL-OMON55718 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON55718 |
|---|---|
| Public title | A phase I/II post-cord blood HCT dendritic cell vaccination trial directed against WT1 for pediatric and young adult acute myeloid leukemia: the U-DANCE-anti-AML-trial |
| Scientific title | A phase I/II post-cord blood HCT dendritic cell vaccination trial directed against WT1 for pediatric and young adult acute myeloid leukemia: the U-DANCE-anti-AML-trial - U-DANCE-anti-AML |
| Primary sponsor | Prinses Máxima Centrum voor Kinderoncologie |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Netherlands |
| Conditions | AML: Acute Myeloid Leukemia/ cancer of blood and bone marrow;10024324 |
| Interventions | CBDC-vaccination (day 0, day 14 and day 28): Patients will receive three WT1 15-mer-peptide pool loaded CBDC-vaccinations starting at 8 weeks post-CBT every 2 weeks (hence week 8, 10 and 12). The CBDC vaccine will be split into two equal… |
| Registration date | Mar 26, 2018 |
| Target size | 54 |
| Secondary IDs | 2018-000698-54;Nederlands Trial Register (registratie volgt nog);NL65115.000.18 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: